Expression of mammaglobin and gross cystic disease fluid protein-15 in breast carcinomas

Human Pathology

Volumn 44, Issue 7, 2013, Pages 1241-1250

  Luo, Ming Hua ^a   Huang, Yu Hua ^b   Ni, Yun Bi ^c   Tsang, Julia Y S ^c   Chan, Siu Ki ^d   Shao, Mu Min ^e   Tse, Gary M ^c  

^a PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHENZHEN UNIVERSITY   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d KWONG WAH HOSPITAL   (Hong Kong)

^e GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Breast carcinoma; Gross cystic disease fluid protein 15; Mammaglobin

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GROSS CYSTIC DISEASE FLUID PROTEIN 15; KI 67 ANTIGEN; MAMMAGLOBIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BASAL LIKE BREAST CANCER; BREAST CARCINOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIMARY TUMOR; PROGNOSIS; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; TISSUE MICROARRAY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARRIER PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAMMAGLOBIN B; MIDDLE AGED; PROGNOSIS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84879213605     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.10.009     Document Type: Article

References (28)

1. D.E. Haagensen Jr., S.A. Gall, J.E. Brazy, J. Giannola, and S.A. Wells Jr. Analysis of amniotic fluid, maternal plasma, and cord blood for a human breast gross cystic disease fluid protein Am J Obstet Gynecol 138 1980 25 32
2. E. Caputo, A. Camarca, and R. Moharram Structural study of GCDFP-15/gp17 in disease versus physiological conditions using a proteomic approach Biochemistry 42 2003 6169 6178
3. G. Mazoujian, G.S. Pinkus, S. Davis, and D.E. Haagensen Jr. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features Am J Pathol 110 1983 105 112
4. R. Bhargava, S. Beriwal, and D.J. Dabbs Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity Am J Clin Pathol 127 2007 103 113
5. F.R. Fritzsche, A. Thomas, and K.J. Winzer Co-expression and prognostic value of gross cystic disease fluid protein 15 and mammaglobin in primary breast cancer Histol Histopathol 22 2007 1221 1230
6. G. Mazoujian, C. Bodian, and D.E. Haagensen Jr. Haagensen CD. Expression of GCDFP-15 in breast carcinomas. Relationship to pathologic and clinical factors Cancer 63 1989 2156 2161
7. M.R. Wick, T.J. Lillemoe, and G.T. Copland Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin Hum Pathol 20 1989 281 287
8. M.A. Watson, and T.P. Fleming Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer Cancer Res 56 1996 860 865
9. E. Sasaki, N. Tsunoda, and Y. Hatanaka Breast-specific expression of MGB1/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers Mod Pathol 20 2007 208 214
10. M. Zafrakas, B. Petschke, and A. Donner Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies BMC Cancer 6 2006 88
11. G.H. Lewis, A.P. Subhawong, and H. Nassar Relationship between molecular subtype of invasive breast carcinoma and expression of gross cystic disease fluid protein 15 and mammaglobin Am J Clin Pathol 135 2011 587 591
12. C.W. Elston, and I.O. Ellis Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 19 1991 403 410
13. S.R. Lakhani, I.O. Ellis, S.J. Schnitee, P.H. Tan, and M.J. van de Vijver World Health Organisation classification of tumors of the breast 2012 IARC Press Lyon
14. M.E. Hammond, D.F. Hayes, and M. Dowsett American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer J Clin Oncol 28 2010 2784 2795
15. A.C. Wolff, M.E. Hammond, and J.N. Schwartz American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer J Clin Oncol 25 2007 118 145
16. A. Goldhirsch, W.C. Wood, and A.S. Coates Strategies for subtypes - dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 Ann Oncol 22 2011 1736 1747
17. T.O. Nielsen, F.D. Hsu, and K. Jensen Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clin Cancer Res 10 2004 5367 5374
18. F. Satoh, S. Umemura, and R.Y. Osamura Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and non-mammary tissue Breast Cancer 7 2000 49 55
19. S.Y. Chia, A.A. Thike, P.Y. Cheok, and P.H. Tan Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors Breast 19 2010 355 359
20. Z. Yan, J. Gidley, and D. Horton Diagnostic utility of mammaglobin and GCDFP-15 in the identification of metastatic breast carcinoma in fluid specimens Diagn Cytopathol 37 2009 475 478
21. M.J. Nunez-Villar, F. Martinez-Arribas, and M. Pollan Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumour phenotype Breast Cancer Res 5 2003 R65 R70
22. P.N. Span, E. Waanders, and P. Manders Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time J Clin Oncol 22 2004 691 698
23. M.A. Watson, S. Dintzis, and C.M. Darrow Mammaglobin expression in primary, metastatic, and occult breast cancer Cancer Res 59 1999 3028 3031
24. S.M. Davion, K.P. Siziopikou, and M.E. Sullivan Cytokeratin 7: a re-evaluation of the 'tried and true' in triple-negative breast cancers Histopathology 2012 10.1111/j.1365-2559.2012.04253.x
25. L. Huo, J. Zhang, and M.Z. Gilcrease GCDFP-15 and mammaglobin expression by immunohistochemistry is of limited utility in triple-negative breast cancer Histopathology 2012 10.1111/j.1365-2559.2012.04344.x
26. C. Reyes, C. Gomez-Fernandez, and M. Nadji Metaplastic and medullary mammary carcinomas do not express mammaglobin Am J Clin Pathol 137 2012 747 752
27. Y. Chao, Q. Wu, M. Acquafondata, R. Dhir, and A. Wells Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases Cancer Microenviron 5 2012 19 28
28. G. Sauer, J. Windisch, and C. Kurzeder Progression of cervical carcinomas is associated with down-regulation of CD9 but strong local re-expression at sites of transendothelial invasion Clin Cancer Res 9 2003 6426 6431.